F&P Healthcare pushes share market higher
The S&P/NZX 50 Index rose 145.14 points, or 1.1 percent, to 13,062.45. Within the index, 22 stocks rose, 21 fell and seven were unchanged. Turnover was $173.3 million.
Much of the Jarden research note focused on an expectation ResMed will have strong growth in its sales of masks, a product F&P Healthcare does not sell.
However, the analysts also said they expected demand for sleep apnoea treatments to recover above pre-covid levels, and for the rapid rise of covid infections & hospitalisations globally to improve earnings from hospital products.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.
![[The Wrap] What the heck is happening at the FMA?](https://goodreturns.publit.io/file/c_fill,w_300,h_200/a6c3bc06-6401-44de-96e2-286c090e132d.jpg)
